All Stories

  1. Investigation of Delefilcon A Contact Lenses for Symptomatic Daily Disposable Contact Lens Wearers with Dry Eye Disease: A Prospective Comparative Study
  2. Evaluation of Lag of Accommodation with Full-Field Diffusion Optics Technology™ (DOT) Contrast Management Spectacle Lenses in Emmetropic Children
  3. Fabrication and Characterization of an Enzyme-Triggered, Therapeutic-Releasing Hydrogel Bandage Contact Lens Material
  4. Evaluating the Performance of Verofilcon A Daily Disposable Contact Lenses in a Group of Heavy Digital Device Users
  5. TFOS Lifestyle: Impact of contact lenses on the ocular surface
  6. In vitro–in vivo correlation of drug release profiles from medicated contact lenses using an in vitro eye blink model
  7. Short-term tolerability of commercial eyelid cleansers: A randomised crossover study
  8. Antiviral Activity of Contemporary Contact Lens Care Solutions against Two Human Seasonal Coronavirus Strains
  9. The impact of contact lenses on meibomian gland morphology
  10. Clinical practice patterns in the management of dry eye disease: A TFOS international survey
  11. Bibliometric analysis of the meibomian gland literature
  12. CLEAR - Contact lens technologies of the future
  13. Developing evidence-based guidance for the treatment of dry eye disease with artificial tear supplements: A six-month multicentre, double-masked randomised controlled trial
  14. Bibliometric analysis of the literature relating to scleral contact lenses
  15. Activity of Deposited Lysozyme on Contemporary Soft Contact Lenses Exposed to Differing Lens Care Systems
  16. The Impact of Incubation Conditions on In Vitro Phosphatidylcholine Deposition on Contact Lens Materials
  17. Global optometrist top 200 research ranking
  18. In vitro analysis of the interaction of tear film inflammatory markers with contemporary contact lens materials
  19. The impact of patient behaviour and care system compliance on reusable soft contact lens complications
  20. Bibliometric analysis of the refractive error field
  21. Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial
  22. In vitro Evaluation of the Location of Cholesteryl Ester Deposits on Monthly Replacement Silicone Hydrogel Contact Lens Materials
  23. Thirty years of ‘quiet eye’ with etafilcon A contact lenses
  24. The ocular surface, coronaviruses and COVID ‐19
  25. Effect of Artificial Tear Formulations on the Metabolic Activity of Human Corneal Epithelial Cells after Exposure to Desiccation
  26. The Impact of Cosmetics on the Physical Dimension and Optical Performance of Contemporary Silicone Hydrogel Contact Lenses
  27. Kinetic Deposition of Polar and Non-polar Lipids on Silicone Hydrogel Contact Lenses
  28. The COVID-19 pandemic: Important considerations for contact lens practitioners
  29. Geographic distribution of corneal staining in symptomatic dry eye
  30. When was the last time you fitted a soft lens?
  31. Cytomorphological assessment of the lid margin in relation to symptoms, contact lens wear and lid wiper epitheliopathy
  32. The efficacy of povidone-iodine, hydrogen peroxide and a chemical multipurpose contact lens care system against Pseudomonas aeruginosa on various lens case surfaces
  33. Global trends in myopia management attitudes and strategies in clinical practice – 2019 Update
  34. Adhesion of Pseudomonas aeruginosa, Achromobacter xylosoxidans, Delftia acidovorans, Stenotrophomonas maltophilia to contact lenses under the influence of an artificial tear solution
  35. Localization of full-length recombinant human proteoglycan-4 in commercial contact lenses using confocal microscopy
  36. The use of preservatives in dry eye drops
  37. The short-term physiological impact of switching reusable silicone hydrogel wearers into a hydrogel daily disposable multifocal
  38. An Eyelid Warming Device for the Management of Meibomian Gland Dysfunction
  39. Hand hygiene is linked to microbial keratitis and corneal inflammatory events
  40. Novel in vitro method to determine pre-lens tear break-up time of hydrogel and silicone hydrogel contact lenses
  41. Efficacy of Contact Lens Care Solutions in Removing Cholesterol Deposits From Silicone Hydrogel Contact Lenses
  42. Efficacy of topical ophthalmic drugs in the treatment of dry eye disease: A systematic literature review
  43. The Case for Using Hydrogen Peroxide Contact Lens Care Solutions
  44. Uptake and Release of Polyvinyl Alcohol from Hydrogel Daily Disposable Contact Lenses
  45. IMI – Clinical Myopia Control Trials and Instrumentation Report
  46. IMI – Industry Guidelines and Ethical Considerations for Myopia Control Report
  47. IMI – Myopia Control Reports Overview and Introduction
  48. IMI – Report on Experimental Models of Emmetropization and Myopia
  49. Impact of a Hyaluronic Acid-Grafted Layer on the Surface Properties of Model Silicone Hydrogel Contact Lenses
  50. Clinical factors associated with contact lens dropout
  51. Determination of the release of PEG and HPMC from nelfilcon A daily disposable contact lenses using a novel in vitro eye model
  52. A novel scale for describing corneal staining
  53. Depth Profile Assessment of the Early Phase Deposition of Lysozyme on Soft Contact Lens Materials Using a Novel In Vitro Eye Model
  54. Comparison of meibomian gland dropout using two infrared imaging devices
  55. Short-Term Comfort Responses Associated With the Use of Eyelid Cleansing Products to Manage Demodex folliculorum
  56. The Impact of Scleral Contact Lens Vault on Visual Acuity and Comfort
  57. Analysis of polyvinyl alcohol release from commercially available daily disposable contact lenses using an in vitro eye model
  58. Spectacle prescriptions review to determine prevalence of ametropia and coverage of frequent replacement soft toric contact lenses
  59. Functional Two- and Three-Dimensional Architectures of Immobilized Metal Nanoparticles
  60. Surface versus bulk activity of lysozyme deposited on hydrogel contact lens materials in vitro
  61. Cytotoxic and inflammatory effects of contact lens solutions on human corneal epithelial cells in vitro
  62. Tear evaporation rates: What does the literature tell us?
  63. The Effect of Denatured Lysozyme on Human Corneal Epithelial Cells
  64. Differential Deposition of Fluorescently Tagged Cholesterol on Commercial Contact Lenses Using a Novel In Vitro Eye Model
  65. Tear osmolarity changes after use of hydroxypropyl-guar-based lubricating eye drops
  66. A Rapid Extraction Method to Quantify Drug Uptake in Contact Lenses
  67. Myopia prevalence in Canadian school children: a pilot study
  68. A single vectored thermal pulsation treatment for meibomian gland dysfunction increases mean comfortable contact lens wearing time by approximately 4 hours per day
  69. In Vitro Effect of Lysozyme on Albumin Deposition to Hydrogel Contact Lens Materials
  70. TFOS DEWS II Report Executive Summary
  71. In vitro release of two anti-muscarinic drugs from soft contact lenses
  72. A Review of Techniques to Measure Protein Sorption to Soft Contact Lenses
  73. Effect of Time on Scleral Lens Settling and Change in Corneal Clearance
  74. Lipid Deposition on Contact Lenses when Using Contemporary Care Solutions
  75. Degradation of proteoglycan 4/lubricin by cathepsin S: Potential mechanism for diminished ocular surface lubrication in Sjögren's syndrome
  76. Consensus report: how to diagnose dry eye
  77. TFOS DEWS II Epidemiology Report
  78. TFOS DEWS II Introduction
  79. TFOS DEWS II Management and Therapy Report
  80. TFOS DEWS II Tear Film Report
  81. Selectivity and localization of lysozyme uptake in contemporary hydrogel contact lens materials
  82. Self versus examiner administration of the Ocular Surface Disease Index©
  83. The relief of dry eye signs and symptoms using a combination of lubricants, lid hygiene and ocular nutraceuticals
  84. A Comparison of Dry Eye Diagnostic Tests Between Symptomatic and Asymptomatic Age-Matched Females
  85. A sixteen year survey of Canadian contact lens prescribing
  86. Release of Moxifloxacin from Contact Lenses Using an In Vitro Eye Model: Impact of Artificial Tear Fluid Composition and Mechanical Rubbing
  87. Pilot Study to Determine the Effect of Lens and Eye Rinsing on Solution-Induced Corneal Staining (SICS)
  88. Towards point-of-care detection of polymicrobial infections: Rapid colorimetric response using a portable spectrophotometer
  89. Effects of Antifungal Soaked Silicone Hydrogel Contact Lenses on Candida albicans in an Agar Eye Model
  90. Interactions between bacterial surface and nanoparticles govern the performance of “chemical nose” biosensors
  91. Impression Cytology of the Lid Wiper Area
  92. Prolonged Ocular Retention of Mucoadhesive Nanoparticle Eye Drop Formulation Enables Treatment of Eye Diseases Using Significantly Reduced Dosage
  93. Contact Lens Comfort
  94. Effect of Short Recovery Periods on Ocular Comfort During Daily Lens Wear
  95. Eyelid Margin and Meibomian Gland Characteristics and Symptoms in Lens Wearers
  96. Impact of Lens Care Solutions on Protein Deposition on Soft Contact Lenses
  97. Lid Wiper Epitheliopathy in Soft Contact Lens Wearers
  98. Microbial Contamination of Contact Lens Storage Cases During Daily Wear Use
  99. Subjective Comfort and Physiology with Modern Contact Lens Care Products
  100. Impact of Eye Cosmetics on the Eye, Adnexa, and Ocular Surface
  101. Corneal Swelling with Cosmetic etafilcon A Lenses versus No Lens Wear
  102. Development of an In Vitro Ocular Platform to Test Contact Lenses
  103. Assessment of biofilm formation of E. meningoseptica, D. acidovorans, and S. maltophilia in lens cases and their growth on recovery media
  104. Expert Views on Innovative Future Uses for Contact Lenses
  105. Global trends in myopia management attitudes and strategies in clinical practice
  106. Release of Fluconazole from Contact Lenses Using a Novel In Vitro Eye Model
  107. Revolutionary Future Uses of Contact Lenses
  108. The Use of Contact Lenses as Biosensors
  109. Variations in observable lid wiper epitheliopathy (LWE) staining patterns in wearers of silicone hydrogel lenses
  110. Colorimetric biosensing of pathogens using gold nanoparticles
  111. In Vitro Cholesterol Deposition on Daily Disposable Contact Lens Materials
  112. A Comparative Study Between an Oil-in-Water Emulsion and Nonlipid Eye Drops Used for Rewetting Contact Lenses
  113. Associations with Meibomian Gland Atrophy in Daily Contact Lens Wearers
  114. Controlling “chemical nose” biosensor characteristics by modulating gold nanoparticle shape and concentration
  115. Effect of Lid Debridement-Scaling in Sjögren Syndrome Dry Eye
  116. In vitro friction testing of contact lenses and human ocular tissues: Effect of proteoglycan 4 (PRG4)
  117. Biological and Clinical Implications of Lysozyme Deposition on Soft Contact Lenses
  118. Atomic force microscopy and Langmuir–Blodgett monolayer technique to assess contact lens deposits and human meibum extracts
  119. Competitive Effects from an Artificial Tear Solution to Protein Adsorption
  120. Impact of Cosmetics on the Physical Dimension and Optical Performance of Silicone Hydrogel Contact Lenses
  121. Impact of Cosmetics on the Surface Properties of Silicone Hydrogel Contact Lenses
  122. Analysis of Using I125Radiolabeling for Quantifying Protein on Contact Lenses
  123. Timolol maleate release from hyaluronic acid-containing model silicone hydrogel contact lens materials
  124. Release of Ciprofloxacin and Moxifloxacin From Daily Disposable Contact Lenses From an In Vitro Eye Model
  125. Efficacy of Antimicrobials against Biofilms of Achromobacter and Pseudomonas
  126. Clinical Performance of Three Silicone Hydrogel Daily Disposable Lenses
  127. Infrared Imaging of Meibomian Glands and Evaluation of the Lipid Layer in Sjogren's Syndrome Patients and Nondry Eye Controls
  128. Tear exchange and contact lenses: A review
  129. “Chemical nose” for the visual identification of emerging ocular pathogens using gold nanostars
  130. Kinetics of Competitive Adsorption between Lysozyme and Lactoferrin on Silicone Hydrogel Contact Lenses and the Effect on Lysozyme Activity
  131. In vitrodrug release of natamycin from β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin-functionalized contact lens materials
  132. Phenylboronic acid modified mucoadhesive nanoparticle drug carriers facilitate weekly treatment of experimentallyinduced dry eye syndrome
  133. Extended Latanoprost Release from Commercial Contact Lenses: In Vitro Studies Using Corneal Models
  134. Comparative Study of Lens Solutions’ Ability to Remove Tear Constituents
  135. Extraction versus In Situ Techniques for Measuring Surface-Adsorbed Lysozyme
  136. In Vitro and In Vivo Evaluation of Novel Ciprofloxacin-Releasing Silicone Hydrogel Contact Lenses
  137. Repeatability of Grading Meibomian Gland Dropout Using Two Infrared Systems
  138. Identification of coagulase-negative staphylococci in daily disposable contact lens wearers
  139. Contact lenses for antifungal ocular drug delivery: a review
  140. Branching and size of CTAB-coated gold nanostars control the colorimetric detection of bacteria
  141. Silicone Allergies and the Eye
  142. Quantification of Conjunctival TNF-α in Aqueous-Deficient Dry Eye
  143. A multi-country assessment of compliance with daily disposable contact lens wear
  144. Human Corneal Epithelial Cell Shedding and Fluorescein Staining in Response to Silicone Hydrogel Lenses and Contact Lens Disinfecting Solutions
  145. The TFOS International Workshop on Contact Lens Discomfort: Executive Summary
  146. The TFOS International Workshop on Contact Lens Discomfort: Introduction
  147. The TFOS International Workshop on Contact Lens Discomfort: Report of the Contact Lens Interactions With the Ocular Surface and Adnexa Subcommittee
  148. The TFOS International Workshop on Contact Lens Discomfort: Report of the Contact Lens Materials, Design, and Care Subcommittee
  149. Factors that Influence In Vitro Cholesterol Deposition on Contact Lenses
  150. In vitrouptake and release of natamycin Dex-b-PLA nanoparticles from model contact lens materials
  151. Comfort Response of Three Silicone Hydrogel Daily Disposable Contact Lenses
  152. Re: Putting vital stains in context
  153. Exploring Compliance
  154. Imaging meibomian glands on a patient with chalazia in the upper and lower lids: A case report
  155. Contemporary dry eye tests
  156. Impact of Silicone Hydrogel Lenses and Solutions on Corneal Epithelial Permeability
  157. Inhibition of Defocus-Induced Myopia in Chickens
  158. Impact of tear film components on the conformational state of lysozyme deposited on contact lenses
  159. Compliance with Lens Replacement and the Interval between Eye Examinations
  160. In Vitro Uptake and Release of Natamycin From Conventional and Silicone Hydrogel Contact Lens Materials
  161. Physical Entrapment of Hyaluronic Acid During Synthesis Results in Extended Release From Model Hydrogel and Silicone Hydrogel Contact Lens Materials
  162. Impact of Time Between Collection and Collection Method on Human Tear Fluid Osmolarity
  163. Optimization of a Fluorescence-based Lysozyme Activity Assay for Contact Lens Studies
  164. 2. Contact lens care and ocular surface homeostasis
  165. 3. Ocular surface health with contact lens wear
  166. Historical overview of imaging the meibomian glands
  167. The Impact of Contemporary Contact Lenses on Contact Lens Discontinuation
  168. Uptake and Release Phenomena in Contact Lens Care by Silicone Hydrogel Lenses
  169. Wettability and Silicone Hydrogel Lenses
  170. Development of Mucoadhesive Drug Delivery System Using Phenylboronic Acid Functionalized Poly(D,L-lactide)-b-Dextran Nanoparticles
  171. The Impact of Intermittent Air Exposure on Lipid Deposition
  172. Measuring the Modulus of Silicone Hydrogel Contact Lenses
  173. Protein Deposition and Clinical Symptoms in Daily Wear of Etafilcon Lenses
  174. Measuring the kinetics and activity of adsorbed proteins:In vitrolysozyme deposited onto hydrogel contact lenses over short time periods
  175. Delivery of Ketotifen Fumarate by Commercial Contact Lens Materials
  176. Molecular Structure of Interfacial Human Meibum Films
  177. The Impact of Tear Film Components on In Vitro Lipid Uptake
  178. Using anIn VitroModel of Lipid Deposition to Assess the Efficiency of Hydrogen Peroxide Solutions to Remove Lipid from Various Contact Lens Materials
  179. Photocrosslinkable hyaluronic acid as an internal wetting agent in model conventional and silicone hydrogel contact lenses
  180. The effects of hyaluronic acid incorporated as a wetting agent on lysozyme denaturation in model contact lens materials
  181. Infrared Imaging of Meibomian Gland Structure Using a Novel Keratograph
  182. Nanomaterials for Ocular Drug Delivery
  183. Impact of Tear Film Components on Lysozyme Deposition to Contact Lenses
  184. Protein deposition on contact lenses: The past, the present, and the future
  185. Correction
  186. Use of a Photographic Manipulation Tool to Assess Corneal Vascular Response
  187. Acetic and Acrylic Acid Molecular Imprinted Model Silicone Hydrogel Materials for Ciprofloxacin-HCl Delivery
  188. The Competing Effects of Hyaluronic and Methacrylic Acid in Model Contact Lenses
  189. Utilization of in vitro methods to determine the biocompatibility of intraocular lens materials
  190. Ability of patients to recall habitual contact lens products and enhancement of recall using photographic aids
  191. Quantification of Non-Polar Lipid Deposits on Senofilcon A Contact Lenses
  192. The University of Waterloo's Centre for Contact Lens Research
  193. The relationship between compliance with lens replacement and contact lens-related problems in silicone hydrogel wearers
  194. Influence of Protein Deposition on Bacterial Adhesion to Contact Lenses
  195. Hyaluronic acid as an internal wetting agent in model DMAA/TRIS contact lenses
  196. Outcomes of wavefront-guided laser in situ keratomileusis for hyperopia
  197. Impact of Multipurpose Solutions Released from Contact Lenses on Corneal Cells
  198. In Vitro Analysis of the Physical Properties of Contact Lens Blister Pack Solutions
  199. Patient Use of Smartphones to Communicate Subjective Data in Clinical Trials
  200. Effects of Silicone Hydrogel Contact Lens Wear on Ocular Surface Sensitivity to Tactile, Pneumatic Mechanical, and Chemical Stimulation
  201. Impact of a Rub and Rinse on Solution-Induced Corneal Staining
  202. Repeatability of Pachymetry and Thinnest Point Localization Using a Fourier-Domain Optical Coherence Tomographer
  203. Clinical performance of different care systems with silicone hydrogel contact lenses
  204. Innovation in contact lenses: basic research and clinical science
  205. Impact of fluorescent probes on albumin sorption profiles to ophthalmic biomaterials
  206. Influence of the Blink Interval on Tear Meniscus Height in Soft Contact Lens and Nonlens Wearers
  207. Tear lipocalin and lysozyme concentrations in postmenopausal women
  208. Comfort and Vision with Silicone Hydrogel Lenses: Effect of Compliance
  209. The Impact of Contact Angle on the Biocompatibility of Biomaterials
  210. Contact Lens Cases: The Missing Link in Contact Lens Safety?
  211. Compliance with Contact Lens Replacement in Canada and the United States
  212. Confocal microscopy and optical coherence tomography imaging of hereditary granular dystrophy
  213. Ex Vivo Protein Deposition on Bi-Weekly Silicone Hydrogel Contact Lenses
  214. In Vitro Contact Angle Analysis and Physical Properties of Blister Pack Solutions of Daily Disposable Contact Lenses
  215. Kinetics of Lysozyme Activity Recovered from Conventional and Silicone Hydrogel Contact Lens Materials
  216. Determination of albumin sorption to intraocular lenses by radiolabeling and confocal laser scanning microscopy
  217. Ex Vivo Protein Deposition on Bi-Weekly Silicone Hydrogel Contact Lenses
  218. Impact of Protein and Lipid on Neutralization Times of Hydrogen Peroxide Care Regimens
  219. Tear Meniscus Height Determination Using the OCT2 and the RTVue-100
  220. Uptake and Release of Dexamethasone Phosphate From Silicone Hydrogel and Group I, II, and IV Hydrogel Contact Lenses
  221. Patient and Practitioner Compliance With Silicone Hydrogel and Daily Disposable Lens Replacement in the United States
  222. Wavefront-guided LASIK for Myopia: Effect on Visual Acuity, Contrast Sensitivity, and Higher Order Aberrations
  223. Contact lens induced papillary conjunctivitis with silicone hydrogel lenses
  224. Efficacy of an Extraction Solvent Used to Quantify Albumin Deposition on Hydrogel Contact Lens Materials
  225. Protein Deposition on a Lathe-Cut Silicone Hydrogel Contact Lens Material
  226. Kinetics of in Vitro Lactoferrin Deposition on Silicone Hydrogel and FDA Group II and Group IV Hydrogel Contact Lens Materials
  227. Localization of Lysozyme Sorption to Conventional and Silicone Hydrogel Contact Lenses Using Confocal Microscopy
  228. Imaging Protein Deposits on Contact Lens Materials
  229. Thickness Mapping of the Cornea and Epithelium Using Optical Coherence Tomography
  230. Conjunctival and Corneal Hyperesthesia in Subjects with Dryness Symptoms
  231. Quartz crystal microbalance study of protein adsorption kinetics on poly(2-hydroxyethyl methacrylate)
  232. Albumin adsorption to contact lens materials: A review
  233. Dry Eye Symptoms Assessed by Four Questionnaires
  234. Epithelial Thickness Changes from the Induction of Myopia with CRTH RGP Contact Lenses
  235. Subjective and Objective Variation of the Tear Film Pre- and Post-Sleep
  236. Tear Lipocalin and Lysozyme in Sj??gren and Non-Sjogren Dry Eye
  237. Size-dependent denaturing kinetics of bovine serum albumin adsorbed onto gold nanospheres
  238. Clinical signs and symptoms in post-menopausal females with symptoms of dry eye
  239. Comfort and Adaptation to Silicone Hydrogel Lenses for Daily Wear
  240. Conjunctival and Corneal Pneumatic Sensitivity Is Associated with Signs and Symptoms of Ocular Dryness
  241. Hyaluronic acid containing hydrogels for the reduction of protein adsorption
  242. Atypical manifestation of upper lid margin staining in silicone hydrogel lens wearers with symptoms of dry eye
  243. Physical Properties of Soft Contact Lens Solutions
  244. A Solid-Phase Assay for the Quantitation of Total Protein Eluted from Balafilcon, Lotrafilcon, and Etafilcon Contact Lenses
  245. Conformational and Quantitative Characterization of Lysozyme Extracted from Galyfilcon and Senofilcon Silicone Hydrogel Contact Lenses
  246. Immobilized hyaluronic acid containing model silicone hydrogels reduce protein adsorption
  247. Microbial Keratitis and the Role of Rub and Rinsing
  248. The Impact of Lipid on Contact Angle Wettability
  249. Apparent time-dependent differences in inferior tear meniscus height in human subjects with mild dry eye symptoms
  250. Confocal Microscopy and Albumin Penetration into Contact Lenses
  251. Variability of the Analysis of the Tear Meniscus Height by Optical Coherence Tomography
  252. Extraction Efficiency of an Extraction Buffer Used to Quantify Lysozyme Deposition on Conventional and Silicone Hydrogel Contact Lens Materials
  253. Growth Factors in the Tear Film: Role in Tissue Maintenance, Wound Healing, and Ocular Pathology
  254. Tear Osmolality and Ferning Patterns in Postmenopausal Women
  255. A Seven Year Survey of the Contact Lens Prescribing Habits of Canadian Optometrists
  256. Assessment of Variation in Bulbar Conjunctival Redness, Temperature, and Blood Flow
  257. Quantity and Conformation of Lysozyme Deposited on Conventional and Silicone Hydrogel Contact Lens Materials Using an In Vitro Model
  258. Contact Lenses in Suboptimal Environments
  259. Corneal Refractive Therapy with Different Lens Materials, Part 1: Corneal, Stromal, and Epithelial Thickness Changes
  260. Lipid Deposition on Hydrogel Contact Lenses: How History Can Help Us Today
  261. In Vitro Assessment of Medical Device Toxicity: Interactions of Benzalkonium Chloride With Silicone-Containing and p-HEMA???Containing Hydrogel Contact Lens Materials
  262. Objective and Subjective Responses in Patients Refitted to Daily-Wear Silicone Hydrogel Contact Lenses
  263. Anomalous thermal denaturing of proteins adsorbed to nanoparticles
  264. Rewetting Drops Containing Surface Active Agents Improve the Clinical Performance of Silicone Hydrogel Contact Lenses
  265. Validity of Pachymetric Measurements by Manipulating the Acoustic Factor of Orbscan II
  266. Kinetics ofIn VitroLysozyme Deposition on Silicone Hydrogel, PMMA, and FDA Groups I, II, and IV Contact Lens Materials
  267. Soft Lens Extended Wear and Complications
  268. Subconjunctival cyst-like formations following impression cytology
  269. Stabilization of Lysozyme Mass Extracted From Lotrafilcon Silicone Hydrogel Contact Lenses
  270. Corneal and Epithelial Thickness Changes After 4 Weeks of Overnight Corneal Refractive Therapy Lens Wear, Measured With Optical Coherence Tomography
  271. Drying methods for XPS analysis of PureVision™, Focus® Night&Day™ and conventional hydrogel contact lenses
  272. Corrigendum to “Tear turnover rate is reduced in patients with symptomatic dry eye” [Contact Lens Anterior Eye 27 (2004) 15–20]
  273. Tear turnover rate is reduced in patients with symptomatic dry eye
  274. Quantitative and conformational characterization of lysozyme deposited on balafilcon and etafilcon contact lens materials
  275. Survey of Bandage Lens Use in North America, October???December 2002
  276. Topographical Thickness of the Epithelium and Total Cornea after Overnight Wear of Reverse-Geometry Rigid Contact Lenses for Myopia Reduction
  277. Precorneal and Pre- and Postlens Tear Film Thickness Measured Indirectly with Optical Coherence Tomography
  278. In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials
  279. Ciprofloxacin Interaction with Silicon-Based and Conventional Hydrogel Contact Lenses
  280. Asymptomatic Corneal Staining Associated with the Use of Balafilcon Silicone-Hydrogel Contact Lenses Disinfected with a Polyaminopropyl Biguanide-Preserved Care Regimen
  281. In vitro evaluation of the dehydration characteristics of silicone hydrogel and conventional hydrogel contact lens materials
  282. Relation between optical coherence tomography and optical pachymetry measurements of corneal swelling induced by hypoxia
  283. The application of counter immunoelectrophoresis (CIE) in ocular protein studies
  284. The measurement of corneal epithelial thickness in response to hypoxia using optical coherence tomography11Proprietary interests: The authors have no proprietary interest in any materials or methods described within this article.
  285. Non-inflammatory corneal complications of contact lens wear
  286. The ex vivo wettability of soft contact lenses
  287. An in Vivo Comparison of the Kinetics of Protein and Lipid Deposition on Group II and Group IV Frequent-Replacement Contact Lenses
  288. Epithelial Inclusions in Association with Mucin Ball Development in High-Oxygen Permeability Hydrogel Lenses
  289. Use of reverse geometry rigid gas permeable contact lenses in the management of the postradial keratotomy patient: review and case report
  290. Clinical comparison of three polyhexanide-preserved multi-purpose contact lens solutions
  291. Spoliation and Clinical Performance of Monthly vs. Three Monthly Group II Disposable Contact Lenses
  292. Disposable contact lenses: a review
  293. Effect of hydrogen peroxide neutralisation onthe fitting characteristics of group IV disposable contact lenses
  294. Pseudomonas corneal ulcers associated with daily wear of disposable hydrogel contact lenses
  295. Corneal ulcers associated with daily wear of disposable hydrogel contact lenses
  296. Possible allergic reactions to cyclopentolate hydrochloride: case reports with literature review of uses and adverse reactions
  297. Bitoric hard and soft lenses in marked ocularastigmatism